POLYVALENT CONJUGATE VACCINE FOR CANCER
    8.
    发明申请
    POLYVALENT CONJUGATE VACCINE FOR CANCER 有权
    多糖联合疫苗用于癌症

    公开(公告)号:US20120263749A1

    公开(公告)日:2012-10-18

    申请号:US13314521

    申请日:2011-12-08

    IPC分类号: A61K39/385 A61P35/00

    摘要: This invention provides a polyvalent vaccine comprising at least two conjugated antigens selected from a group containing glycolipid antigen, polysaccharide antigen, mucin antigen, glycosylated mucin antigen and an appropriate adjuvant. This invention also provides a multivalent vaccine comprising at least two of the following: glycosylated MUC-1-32mer, Globo H, GM2, Ley, Tn(c), sTN(c), and TF(c). This invention provides the vaccine above, wherein the adjuvant is saponin-based adjuvant. This invention provides a method for inducing immune response in a subject comprising administering an effective amount of the vaccine above to the subject. Finally, this invention provides a method for treating cancer in a subject comprising administering an appropriate amount of the vaccine above to the subject.

    摘要翻译: 本发明提供了包含至少两种选自包含糖脂抗原,多糖抗原,粘蛋白抗原,糖基化粘蛋白抗原和合适佐剂的缀合抗原的多价疫苗。 本发明还提供了包含以下至少两种的多价疫苗:糖基化MUC-1-32mer,Globo H,GM2,Ley,Tn(c),sTN(c)和TF(c)。 本发明提供上述疫苗,其中佐剂是基于皂苷的佐剂。 本发明提供了一种在受试者中诱导免疫应答的方法,包括向受试者施用有效量的上述疫苗。 最后,本发明提供了一种用于治疗受试者的癌症的方法,包括向受试者施用适量的上述疫苗。